We are live on
!
Find out more
ACM
Arlington Capital Management Portfolio holdings
AUM
$161M
1-Year Est. Return
38.38%
This Fund
S&P 500
This Quarter
Est. Return
+9.06%
1 Year Est. Return
+38.38%
3 Year Est. Return
+153.55%
5 Year Est. Return
+294.8%
10 Year Est. Return
+509.37%
AUM
$140M
AUM Growth
+$21.5M
(+18%)
Cap. Flow
+$12M
Cap. Flow
% of AUM
8.59%
Top 10 Holdings %
Top 10 Hldgs %
80.09%
Holding
39
New
8
Increased
16
Reduced
6
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
|
+$7.03M |
| 2 |
BioMarin Pharmaceuticals
BMRN
|
+$1.97M |
| 3 |
Cohen & Steers REIT and Preferred and Income Fund
RNP
|
+$1.43M |
| 4 |
iShares Biotechnology ETF
IBB
|
+$1.4M |
| 5 |
FirstEnergy
FE
|
+$1.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares China Large-Cap ETF
FXI
|
+$6.11M |
| 2 |
Lumen
LUMN
|
+$1.36M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$1.27M |
| 4 |
HPF
John Hancock Preferred Income Fund II
HPF
|
+$983K |
| 5 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$811K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 12.41% |
| 2 | Healthcare | 10.9% |
| 3 | Industrials | 9.12% |
| 4 | Financials | 1.76% |
| 5 | Real Estate | 1.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FLY
26
DELISTED
Fly Leasing Limited
FLY
| $348K | 0.25% |
+23,935
| New | +$340K |
|
|
ATCO
27
DELISTED
Atlas Corp.
ATCO
| $345K | 0.25% |
18,937
-859
| -4% | -$15.7K |
|
28
Banco Santander Chile
BSAC
$16.3B
| $316K | 0.23% |
+42,409
| New | +$859K |
|
29
Dominion Energy
D
$60.8B
| $294K | 0.21% |
+4,150
| New | +$308K |
|
30
Nuveen Multi-Market Income Fund
JMM
$54.6M
| $188K | 0.13% |
+24,788
| New | +$191K |
|
31
AstraZeneca
AZN
$263B
| – | – |
-3,953
| Closed | -$278K |
|
|
32
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$15B
| – | – |
-7,392
| Closed | -$811K |
|
|
EMD
33
Western Asset Emerging Markets Debt Fund
EMD
$609M
| – | – |
-10,155
| Closed | -$160K |
|
34
Exelon
EXC
$47.2B
| – | – |
-8,293
| Closed | -$219K |
|
|
35
iShares China Large-Cap ETF
FXI
$4.37B
| – | – |
-146,741
| Closed | -$6.11M |
|
|
HPF
36
John Hancock Preferred Income Fund II
HPF
$343M
| – | – |
-48,325
| Closed | -$983K |
|
|
37
Lumen
LUMN
$6.57B
| – | – |
-34,405
| Closed | -$1.36M |
|
|
38
Regeneron Pharmaceuticals
REGN
$78.5B
| – | – |
-3,086
| Closed | -$1.27M |
|
39
AT&T
T
$159B
| – | – |
-18,209
| Closed | -$462K |
|
Similar funds
FPWM
GWA
RCWM
IC
PCC
MWM
CF
CCW
Arlington Capital Management's Q1 2015 Portfolio in Review
As of Q1 2015, Arlington Capital Management held 39 positions worth $140M, up 18% from $118M the previous quarter. Its ten largest holdings account for 80% of the portfolio.
Arlington Capital Management deployed $12M of net new capital in Q1 2015, opening 8 new positions and adding to 16 existing holdings. Its largest new stake was Cohen & Steers REIT and Preferred and Income Fund: 73,445 shares worth $1.43M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 12% of assets, up from 12% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was JP Morgan Alerian MLP Index ETN 5/24/24, an estimated $58.9K trimmed.
- Arlington Capital Management's largest Q1 2015 buy was Cohen & Steers REIT and Preferred and Income Fund: 73,445 shares worth $1.43M.
- Arlington Capital Management added most to Xtrackers Harvest CSI 300 China A-Shares ETF in Q1 2015, an estimated $7.03M increase.
- Arlington Capital Management's biggest Q1 2015 reduction was JP Morgan Alerian MLP Index ETN 5/24/24, cutting an estimated $58.9K.
- Arlington Capital Management fully exited iShares China Large-Cap ETF in Q1 2015, selling an estimated $6.11M.
- Arlington Capital Management's ten largest holdings make up 80% of its $140M portfolio in Q1 2015.
- Arlington Capital Management opened 8 new positions and closed 9 in Q1 2015.
- Arlington Capital Management's portfolio value rose 18% quarter-over-quarter to $140M.
Based on Arlington Capital Management's 13F filing for Q1 2015, filed 12 May 2015.